RSI Alert For Covidien (COV)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Covidien plc ( COV) entered into oversold territory, hitting an RSI reading of 27.5, after changing hands as low as $61.63 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 56.5. A bullish investor could look at COV's 27.5 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of COV shares:

Find out what 9 other oversold stocks you need to know about »

Covidien plc 1 Year Performance Chart

Looking at the chart above, COV's low point in its 52 week range is $50.25 per share, with $68.83 as the 52 week high point — that compares with a last trade of $62.00.

According to the ETF Finder at ETF Channel, COV makes up 8.10% of the iShares Dow Jones U.S. Medical Devices Index Fund ETF ( IHI) which is trading lower by about 1.1% on the day Friday.


If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback